The WHO describes the mixed phenotype acute leukemia (MPAL) classification based on the expression of strictly specific T-lymphoid (cytoplasmic CD3) and myeloid (myeloperoxidase (MPO)) antigens, the latter shown by either flow cytometry or cytochemistry and/or clear evidence of monocytic differentiation. Here, MPO is linked to acute leukemia.